Pharmaceutical Development Advisor, Board Member
Dr. Lebeaut is an experienced senior executive, global leader in pharmaceutical and biopharmaceutical R&D, and pediatrician. Dr. Lebeaut most recently served as CEO of I-ACT for Children, a non-profit organization dedicated to advancing pediatric clinical development. He has successfully contributed to the development and global commercialization of therapeutic advances in oncology, infectious diseases, pediatrics, genetic diseases, gastroenterology, cardiometabolism, and neurology. He also served as Chief Scientific Officer at IPSEN Bioscience in Cambridge, Massachusetts, and has held senior R&D responsibilities at Sanofi, Novartis, Bluebird Bio, Axcan Pharmaceuticals, and Schering-Plough Research Institute.